相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Efficacy and safety of medical cannabinoids in older subjects: A systematic review
G. A. H. van den Elsen et al.
AGEING RESEARCH REVIEWS (2014)
Dronabinol for the Treatment of Agitation and Aggressive Behavior in Acutely Hospitalized Severely Demented Patients with Noncognitive Behavioral Symptoms
Matthew R. Woodward et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2014)
Safety and pharmacokinetics of oral delta-9-tetrahydrocannabinol in healthy older subjects: A randomized controlled trial
Amir I. A. Ahmed et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2014)
Ultralow Doses of Cannabinoid Drugs Protect the Mouse Brain From Inflammation-Induced Cognitive Damage
Miriam Fishbein-Kaminietsky et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2014)
MEDICINAL USE OF CANNABIS AND CANNABINOIDS IN OLDER ADULTS: WHERE IS THE EVIDENCE?
Amir I. A. Ahmed et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2014)
A phase I study to assess the effect of food on the single dose bioavailability of the THC/CBD oromucosal spray
C. G. Stott et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Visual analogue scales: scale recalibration by patients with dementia and their proxies
Alexander M. M. Arons et al.
QUALITY OF LIFE RESEARCH (2013)
Novel Δ9-tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects
Linda E. Klumpers et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2012)
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
Guy M. McKhann et al.
ALZHEIMERS & DEMENTIA (2011)
Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials
Mary E. Lynch et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Randomized, Controlled Crossover Trial of Dronabinol, 2.5 mg, for Agitation in 2 Patients With Dementia
Sebastian Walther et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2011)
Age-Related Pharmacokinetic and Pharmacodynamic Changes and Related Risk of Adverse Drug Reactions
A. Corsonello et al.
CURRENT MEDICINAL CHEMISTRY (2010)
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
R. G. Pertwee et al.
PHARMACOLOGICAL REVIEWS (2010)
Effect of intrapulmonary tetrahydrocannabinol administration in humans
L. Zuurman et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2008)
Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia
S Walther et al.
PSYCHOPHARMACOLOGY (2006)
Pharmacy practice, research, education, and advocacy for older adults
SA Linnebur et al.
PHARMACOTHERAPY (2005)
Cannabis for dyskinesia in Parkinson disease - A randomized double-blind crossover study
CB Carroll et al.
NEUROLOGY (2004)
The therapeutic potential of cannabis
D Baker et al.
LANCET NEUROLOGY (2003)
Are cannabinoids an effective and safe treatment option in the management of pain?: A qualitative systematic review
FA Campbell et al.
BMJ-BRITISH MEDICAL JOURNAL (2001)
分享论文
